Analgesic actions of adenosine A1 receptor along axonal tracts in chronic pain
Analgesic actions of adenosine A1 receptor along axonal tracts in chronic pain
批准号:
8562613
负责人:
Takahiro Takano
金额:
$28.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2018-06-30
关键词:
Absence of pain sensationAcid PhosphataseAction PotentialsAcupuncture AnalgesiaAcupuncture PointsAcupuncture procedureAcuteAddressAdenosineAdenosine A1 ReceptorAdjuvantAffectAgonistAmericanAnalgesicsAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAttenuatedBiologicalCaffeineCharacteristicsChronic inflammatory painClinicalClinical TrialsConsumptionDataDevelopmentExperimental ModelsFiberFutureHyperalgesiaInflammation MediatorsInflammatoryInjection of therapeutic agentInstitute of Medicine (U.S.)LeadLinkMediatingModelingMolecularMusPainPain ResearchPain managementPathway interactionsPatientsPeripheralPeripheral NervesPersistent painProcessPurinergic P1 ReceptorsReceptor SignalingResearch PersonnelSeriesSignal PathwaySignal TransductionSocietiesSpinal CordSubstance PTestingTherapeuticUnited Statesadenosine receptor activationalternative treatmentankle jointattenuationbasechronic painexhausthuman subjectin vivoinflammatory paininsightmouse modelnovel strategiesnovel therapeuticspublic health relevancereceptorreceptor-mediated signalingresearch studysciatic nervetransmission processtreatment strategy
中文摘要
描述(由申请者提供):超过1.16亿美国人与持续的疼痛作斗争。由于目前的治疗方案不足以解决广泛的慢性疼痛表现,针灸是一个受欢迎的替代方案。然而,由于我们对其生物学基础的不完全了解,针灸仍然存在争议。在最近的实验中,我们已经证明针灸与穴位局部腺苷浓度的增加有关,无论是在人类受试者还是在小鼠身上。此外,在小鼠足三里穴位局部应用腺苷A1受体激动剂可模拟针灸的止痛作用。其他研究人员已经证明,局部使用PAP(一种可以将AMP转化为腺苷的酸性磷酸酶)可以缓解数天的疼痛。由于大多数穴位都位于离周围神经很近的地方,我们推测疼痛纤维中的局部A1受体信号可以减少痛前传入信息的传递。根据穴位递送的腺苷能有效降低慢性疼痛小鼠坐骨神经A(Delta)和C痛纤维的传导的研究结果,我们建议评估外周疼痛通路中的A1受体信号是否构成了一种新的治疗策略,可以提供比针灸本身更持久的止痛。目的1将评估A1受体介导的持续性炎性疼痛小鼠模型中的信号转导。在坐骨神经中记录腺苷信号在足三里穴位操作前后的复合动作电位。A1受体KO小鼠将作为阴性对照。重要的是,这些实验还将评估咖啡因(一种腺苷受体拮抗剂)是否使针灸诱导的止痛无效。这个问题很重要,因为到目前为止还没有临床试验认为咖啡因可能直接抵消针灸的临床益处。目的2探讨在慢性炎症性疼痛的实验模型中,轴索束上腺苷A1受体信号的持续增加是否能引发持续的疼痛抑制。初步数据显示,在足三里穴位注射CD73(一种将内源性AMP转化为腺苷的胞外核苷酸酶)可以延长疼痛缓解时间。目的3,我们将建立在初步数据的基础上,表明CD73在足三里穴给药降低了炎性疼痛小鼠脊髓中P物质的水平。鉴于腺苷的内源性抗炎作用,我们将检验这样一种假设,即传入束上的腺苷信号可以抑制痛觉过敏,导致脊髓中炎症介质的减少;然后将观察到的抗炎作用与长期针灸进行比较。建议的实验将促进我们对外周疼痛通路上腺苷信号的急性和持久止痛作用的分子通路的理解。我们希望这些研究有助于开发治疗慢性疼痛的新治疗策略,并为深入了解针灸的生物学基础提供额外的目的。
英文摘要
DESCRIPTION (provided by applicant): More than 116 million Americans struggle with persistent pain. As current treatment options do not adequately address the wide spectrum of chronic pain presentations, acupuncture is a popular alternative. Yet, acupuncture remains controversial due to our incomplete understanding of its biological basis. In recent experiments we have shown that acupuncture is linked to an increase in the local concentration of adenosine at the acupoint, in both human subjects and in mice. Moreover, local administration of an adenosine A1 receptor agonist in the Zusanli acupoint in mice mimicked the analgesic actions of acupuncture. Other investigators have shown that local administration of PAP (an acid phosphatase that can convert AMP to adenosine) provides days of pain reduction. As most acupoints are located in close proximity to peripheral nerves, we speculate that local A1 receptor signaling in pain fibers can reduce the transmission of pro-algesic afferent input. Based on the findings that adenosine, delivered in the acupoint, potently reduces the conductance of A(delta) and C pain fibers in the sciatic nerve in mice with chronic pain, we propose to evaluate whether A1 receptor signaling in peripheral pain pathways constitutes a novel therapeutic strategy that could provide longer-lasting analgesia than acupuncture itself. Aim 1 will evaluate A1 receptor mediated signaling in mouse models of persistent inflammatory pain. The compound action potential will be recorded in the sciatic nerve before and after manipulation of adenosine signaling at the Zusanli acupoint. A1 receptor KO mice will serve as a negative control. Importantly, these experiments will also evaluate whether caffeine (an adenosine receptor antagonist) nullifies acupuncture induced analgesia. This issue is important because no clinical trials to date have considered that caffeine may directly counteract the clinical benefits of acupuncture. Aim 2 asks whether prolonged increases in adenosine A1 receptor signaling along axonal tracts can trigger a persistent suppression of pain in experimental models of chronic inflammatory pain. Preliminary data show that administration of CD73 (an ectonucleotidase that converts endogenous AMP to adenosine) in the Zusanli acupoint provides prolonged pain relief. Aim 3, we will build on preliminary data showing that administration of CD73 in the Zusanli acupoint reduced the level of substance P in spinal cord in mice with inflammatory pain. Given adenosine's endogenous anti-inflammatory profile, we will test the hypothesis that the adenosine signaling along afferent tracts suppresses hyperalgesia, leading to a reduction of inflammatory mediators in the spinal cord; then compare the observed anti-inflammatory action with long-term acupuncture. The proposed experiments will advance our understanding of the molecular pathways involved in acute and long-lasting analgesic actions of adenosine signaling along peripheral pain pathways. We hope these studies lead to the development of novel therapeutic strategies for the treatment of chronic pain, with the additional aim of providing insight into the biological basis of acupuncture.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analgesic actions of adenosine A1 receptor along axonal tracts in chronic pain
-
批准号:9101984
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:Takahiro Takano
-
依托单位:
Analgesic actions of adenosine A1 receptor along axonal tracts in chronic pain
-
批准号:9294975
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:Takahiro Takano
-
依托单位:
海外基金